Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1051 AL 1065

Clearance of amyloid-beta in Alzheimer's disease: shifting the action site from center to periphery

Liu YH, Wang YR, Xiang Y, Zhou HD, Giunta B, Mañucat-Tan NB, Tan J, Zhou XF, Wang YJ.

Mol Neurobiol. 2015 Feb;51(1):1-7. doi: 10.1007/s12035-014-8694-9. Epub 2014 Apr 15.

Herbal medicine in the treatment of Alzheimer's disease

Wu JG, Wang YY, Zhang ZL, Yu B.

Chin J Integr Med. 2015 Feb;21(2):102-7. doi: 10.1007/s11655-014-1337-y. Epub 2014 Apr 22.

Multistimulation group therapy in Alzheimer's disease promotes changes in brain functioning

Baglio F, Griffanti L, Saibene FL, Ricci C, Alberoni M, Critelli R, Villanelli F, Fioravanti R, Mantovani F, D'amico A, Cabinio M, Preti MG, Nemni R, Farina E.

Neurorehabil Neural Repair. 2015 Jan;29(1):13-24. doi: 10.1177/1545968314532833. Epub 2014 Apr 29.

Cognitive reserve and Alzheimer's disease

Xu W, Yu JT, Tan MS, Tan L.

Mol Neurobiol. 2015 Feb;51(1):187-208. doi: 10.1007/s12035-014-8720-y. Epub 2014 May 4.

Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways

Lakey-Beitia J, Berrocal R, Rao KS, Durant AA.

Mol Neurobiol. 2015 Apr;51(2):466-79. doi: 10.1007/s12035-014-8722-9. Epub 2014 May 15.

Interconnection between brain and retinal neurodegenerations

Jindal V.

Mol Neurobiol. 2015;51(3):885-92. doi: 10.1007/s12035-014-8733-6. Epub 2014 May 15.

The Role of SORL1 in Alzheimer's Disease

Yin RH, Yu JT, Tan L.

Mol Neurobiol. 2015;51(3):909-18. doi: 10.1007/s12035-014-8742-5. Epub 2014 May 16.

The role of cholesterol metabolism in Alzheimer's disease

Sun JH, Yu JT, Tan L.

Mol Neurobiol. 2015;51(3):947-65. doi: 10.1007/s12035-014-8749-y. Epub 2014 May 18.

Epigenomics of Alzheimer's disease

Bennett DA, Yu L, Yang J, Srivastava GP, Aubin C, De Jager PL.

Transl Res. 2015 Jan;165(1):200-20. doi: 10.1016/j.trsl.2014.05.006. Epub 2014 May 16.

The relationship between changes in quality of life outcomes and progression of Alzheimer's disease: results from the dependence in AD in England 2 longitudinal study

Trigg R, Jones RW, Knapp M, King D, Lacey LA; DADE-2 Investigator Groups.

Int J Geriatr Psychiatry. 2015 Apr;30(4):400-8. doi: 10.1002/gps.4150. Epub 2014 Jun 12.

PLD3 in Alzheimer's disease

Wang J, Yu JT, Tan L.

Mol Neurobiol. 2015 Apr;51(2):480-6. doi: 10.1007/s12035-014-8779-5. Epub 2014 Jun 17.

Comparison of QoL-AD and DQoL in elderly with Alzheimer's disease

Wolak-Thierry A, Novella JL, Barbe C, Morrone I, Mahmoudi R, Jolly D.

Aging Ment Health. 2015;19(3):274-8. doi: 10.1080/13607863.2014.927822. Epub 2014 Jun 20.

An ambient assisted living approach in designing domiciliary services combined with innovative technologies for patients with Alzheimer's disease: a case study

Cavallo F, Aquilano M, Arvati M.

Am J Alzheimers Dis Other Demen. 2015 Feb;30(1):69-77. doi: 10.1177/1533317514539724. Epub 2014 Jun 20.

Protective effects of Humanin and calmodulin-like skin protein in Alzheimer's disease and broad range of abnormalities

Matsuoka M.

Mol Neurobiol. 2015;51(3):1232-9. doi: 10.1007/s12035-014-8799-1. Epub 2014 Jun 27.

The six-item Clock Drawing Test - reliability and validity in mild Alzheimer's disease

Jørgensen K, Kristensen MK, Waldemar G, Vogel A.

Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(3):301-11. doi: 10.1080/13825585.2014.932325. Epub 2014 Jun 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias